Craig-Hallum raised the firm’s price target on Koru Medical (KRMD) to $5 from $4 and keeps a Buy rating on the shares. The firm notes Koru Medical reported Q3 ahead of expectations, with guidance raised and importantly, cash flow breakeven reiterated for Q4.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD: